Innovation Adoption: ‘Medtech’s Ongoing Challenge Of The Day’
UK Health Care System Faces Tough Short- And Medium-Term Conditions
Executive Summary
UK ministers are increasingly focusing on the need to improve uptake of new technologies in the National Health Service. Ambitious programs have been launched but implementing them effectively for lasting change in a delivery system under acute stress is a challenge of a different order.
You may also be interested in...
Bringing Polygenics Into Cardiovascular Disease Diagnosis
GENinCode’s mission as a clinical-genetic diagnostic company is to apply a combination of polygenics, a proprietary bioinformatics platform and AI to risk-assess and prevent cardiovascular disease. The company set a UK precedent in being the first to have a CVD commercial polygenic test implemented in the NHS and keenly awaits another milestone, US 510k clearance in 2024.
Bringing Polygenics Into Cardiovascular Disease Diagnosis
GENinCode’s mission as a clinical-genetic diagnostic company is to apply a combination of polygenics, a proprietary bioinformatics platform and AI to risk-assess and prevent cardiovascular disease. The company set a UK precedent in being the first to have a CVD commercial polygenic test implemented in the NHS and keenly awaits another milestone, US 510k clearance in 2024.
UK’s IDAP Medtech Innovation Pilot Will Take ‘Portfolio Approach’
The pilot of eight innovative medtech and healthtech products that address unmet needs will close for applications on 29 October. A UK government webinar answered questions on rationale and processes for eligible technologies.